Chiou-Feng Lin Selected Research

Glycogen Synthase (Synthase I)

4/2022	Role of Glycogen Synthase Kinase-3 in Interferon-γ-Mediated Immune Hepatitis.
7/2021	Pharmacologically Inhibiting Glycogen Synthase Kinase-3β Ameliorates Renal Inflammation and Nephrotoxicity in an Animal Model of Cisplatin-Induced Acute Kidney Injury.
1/2019	Streptolysin S induces mitochondrial damage and macrophage death through inhibiting degradation of glycogen synthase kinase-3β in Streptococcus pyogenes infection.
1/2013	Regulatory role of GSK-3 β on NF- κ B, nitric oxide, and TNF- α in group A streptococcal infection.
10/2012	Inhibiting glycogen synthase kinase-3 decreases 12-O-tetradecanoylphorbol-13-acetate-induced interferon-γ-mediated skin inflammation.
10/2012	Glycogen synthase kinase-3β regulates anti-inflammatory property of fluoxetine.
10/2011	Glucosylceramide synthase inhibitor PDMP sensitizes chronic myeloid leukemia T315I mutant to Bcr-Abl inhibitor and cooperatively induces glycogen synthase kinase-3-regulated apoptosis.
7/2009	Glycogen synthase kinase-3beta facilitates IFN-gamma-induced STAT1 activation by regulating Src homology-2 domain-containing phosphatase 2.
5/2009	Glycogen synthase kinase-3beta mediates endoplasmic reticulum stress-induced lysosomal apoptosis in leukemia.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Chiou-Feng Lin Research Topics

Disease

36	Infections 01/2022 - 01/2003
22	Inflammation (Inflammations) 07/2021 - 10/2008
18	Neoplasms (Cancer) 01/2022 - 04/2008
15	Dengue (Dengue Fever) 01/2021 - 01/2003
8	Adenocarcinoma of Lung 02/2019 - 05/2012
7	Necrosis 07/2021 - 01/2010
5	Sepsis (Septicemia) 07/2021 - 10/2010
4	Acute Kidney Injury (Acute Renal Failure) 07/2021 - 01/2012
4	Severe Dengue 01/2021 - 01/2004
4	Leukemia 01/2015 - 05/2009
3	Streptococcal Infections (Streptococcal Infection) 01/2019 - 02/2007
3	Virus Diseases (Viral Diseases) 01/2018 - 01/2013
3	Starvation 01/2018 - 11/2012
3	Communicable Diseases (Infectious Diseases) 09/2017 - 01/2010
3	Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome) 07/2015 - 10/2011
3	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 10/2011 - 05/2009
2	Mitochondrial Diseases (Mitochondrial Disease) 01/2022 - 05/2012
2	Pneumonia (Pneumonitis) 01/2022 - 02/2013
2	Fibrosis (Cirrhosis) 01/2022 - 01/2021
2	Lung Neoplasms (Lung Cancer) 01/2022 - 02/2019
2	Disease Progression 01/2021 - 01/2021
2	Reinfection 01/2019 - 01/2019
2	Hypoxia (Hypoxemia) 01/2018 - 01/2011
2	Viral Encephalitis 01/2018 - 01/2016
2	Stomach Neoplasms (Stomach Cancer) 03/2016 - 11/2014
2	Ataxia Telangiectasia (Louis Bar Syndrome) 02/2016 - 05/2012
2	Acute Lung Injury 07/2015 - 10/2011
2	Acute Promyelocytic Leukemia 01/2015 - 03/2014
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 07/2014 - 09/2012
2	Hemorrhage 01/2014 - 08/2009
2	Lung Injury 10/2011 - 01/2010
1	Liver Diseases (Liver Disease) 04/2022
1	Hepatitis 04/2022
1	Chronic Kidney Failure (Chronic Renal Failure) 01/2022
1	Neoplasm Metastasis (Metastasis) 01/2022
1	Wounds and Injuries (Trauma) 11/2021
1	Liver Neoplasms (Liver Cancer) 10/2021

Drug/Important Bio-Agent (IBA)

20	CytokinesIBA 01/2022 - 01/2004
10	Proteins (Proteins, Gene)FDA Link 10/2021 - 08/2009
9	Glycogen Synthase (Synthase I)IBA 04/2022 - 05/2009
9	InterferonsIBA 04/2022 - 10/2012
7	Antiviral Agents (Antivirals)IBA 01/2021 - 01/2013
7	AntibodiesIBA 05/2015 - 01/2003
6	Glycogen Synthase Kinase 3IBA 04/2022 - 10/2011
6	Phosphoric Monoester Hydrolases (Phosphatases)IBA 01/2021 - 12/2013
6	Glycogen Synthase KinasesIBA 03/2016 - 09/2009
6	CaspasesIBA 02/2016 - 01/2003
6	Reactive Oxygen Species (Oxygen Radicals)IBA 07/2015 - 09/2010
5	InterleukinsIBA 01/2021 - 10/2010
5	Annexin A2 (Annexin II)IBA 01/2014 - 10/2009
5	CeramidesIBA 10/2011 - 04/2008
4	Biomarkers (Surrogate Marker)IBA 07/2021 - 01/2012
4	ChemokinesIBA 07/2021 - 07/2015
4	Cisplatin (Platino)FDA LinkGeneric 07/2021 - 08/2011
4	Propofol (Diprivan)FDA LinkGeneric 01/2021 - 03/2011
4	AutoantibodiesIBA 01/2019 - 01/2003
4	TensinsIBA 03/2016 - 12/2013
4	LipopolysaccharidesIBA 07/2015 - 09/2009
4	Macrophage Migration-Inhibitory FactorsIBA 10/2014 - 10/2010
4	Dengue VaccinesIBA 06/2013 - 08/2009
4	p38 Mitogen-Activated Protein KinasesIBA 11/2012 - 10/2010
4	SphingolipidsIBA 10/2011 - 01/2011
3	Anti-Bacterial Agents (Antibiotics)IBA 01/2022 - 03/2011
3	VaccinesIBA 01/2022 - 01/2010
3	Vinorelbine (Navelbine)FDA LinkGeneric 01/2018 - 07/2014
3	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2016 - 04/2005
3	ceramide glucosyltransferaseIBA 08/2015 - 10/2011
3	Caspase 3 (Caspase-3)IBA 01/2015 - 11/2012
3	Small Interfering RNA (siRNA)IBA 11/2014 - 05/2012
3	Interleukin-10 (Interleukin 10)IBA 11/2014 - 09/2009
2	Therapeutic UsesIBA 01/2022 - 10/2017
2	Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA 01/2022 - 10/2012
2	Anesthetics (Anesthetic Agents)IBA 01/2021 - 03/2011
2	Interleukin-18 (Interleukin 18)IBA 01/2021 - 01/2021
2	IntegrinsIBA 10/2019 - 05/2012
2	RNA (Ribonucleic Acid)IBA 12/2018 - 01/2017
2	Toll-Like Receptor 3IBA 12/2018 - 01/2016
2	Tyrosine Kinase InhibitorsIBA 01/2018 - 01/2018
2	TOR Serine-Threonine KinasesIBA 01/2018 - 11/2012
2	Transcription Factors (Transcription Factor)IBA 09/2017 - 01/2015
2	Pharmaceutical PreparationsIBA 01/2017 - 08/2011
2	Galectin 3 (LGALS3)IBA 03/2016 - 08/2011
2	Histones (Histone)IBA 02/2016 - 11/2012
2	erythrogenic toxinIBA 01/2016 - 02/2007
2	AlkaloidsIBA 08/2015 - 05/2012
2	kallistatinIBA 07/2015 - 02/2013
2	Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA 01/2015 - 08/2011
2	Nitric Oxide (Nitrogen Monoxide)FDA Link 01/2015 - 01/2013
2	Complement System Proteins (Complement)IBA 01/2014 - 01/2003
2	LipidsIBA 01/2011 - 04/2008
2	Interleukin-6 (Interleukin 6)IBA 10/2010 - 01/2010
2	Interleukin-8 (Interleukin 8)IBA 10/2010 - 01/2010
2	Glycogen Synthase Kinase 3 betaIBA 07/2009 - 05/2009
2	Interferon-gamma (Interferon, gamma)IBA 10/2008 - 04/2005
1	ChAdOx1 nCoV-19IBA 01/2022
1	Protein Tyrosine PhosphatasesIBA 01/2022
1	HMGB1 Protein (HMG1)IBA 10/2021
1	Cell Adhesion MoleculesIBA 07/2021

Therapy/Procedure

3	Drug Therapy (Chemotherapy) 01/2018 - 04/2008
2	Therapeutics 01/2022 - 01/2011